1. Home
  2. WLDS vs XBIO Comparison

WLDS vs XBIO Comparison

Compare WLDS & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wearable Devices Ltd.

WLDS

Wearable Devices Ltd.

HOLD

Current Price

$1.70

Market Cap

7.7M

ML Signal

HOLD

Logo Xenetic Biosciences Inc.

XBIO

Xenetic Biosciences Inc.

HOLD

Current Price

$4.10

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDS
XBIO
Founded
2014
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
6.9M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
WLDS
XBIO
Price
$1.70
$4.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
211.8K
31.1K
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.52
EPS
N/A
N/A
Revenue
N/A
$2,976,411.00
Revenue This Year
N/A
$2.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.04
52 Week Low
$0.63
$1.90
52 Week High
$11.40
$13.93

Technical Indicators

Market Signals
Indicator
WLDS
XBIO
Relative Strength Index (RSI) 39.41 62.03
Support Level $1.21 $2.82
Resistance Level $2.02 N/A
Average True Range (ATR) 0.29 0.35
MACD -0.09 0.01
Stochastic Oscillator 24.00 54.53

Price Performance

Historical Comparison
WLDS
XBIO

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

About XBIO Xenetic Biosciences Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Share on Social Networks: